Antioxidants (pharmacology) < Antioxidants (therapeutic use) < Antiparasitic Agents (adverse effects)

Facettes :

List of bibliographic references indexed by Antioxidants (therapeutic use)

Number of relevant bibliographic references: 10.

Ident.	Authors (with country if any)	Title
000D98 (2012)	Caterina Mariotti [Italie] ; Roberto Fancellu ; Serena Caldarazzo ; Lorenzo Nanetti ; Daniela Di Bella ; Massimo Plumari ; Giuseppe Lauria ; Maria D. Cappellini ; Lorena Duca ; Alessandra Solari ; Franco Taroni	Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial.
000F03 (2012)	David R. Lynch [États-Unis] ; Steven M. Willi ; Robert B. Wilson ; M Grazia Cotticelli ; Karlla W. Brigatti ; Eric C. Deutsch ; Olena Kucheruk ; William Shrader ; Patrice Rioux ; Guy Miller ; Amale Hawi ; Thomas Sciascia	A0001 in Friedreich ataxia: biochemical characterization and effects in a clinical trial.
001C51 (2010)	Seung Hun Lee [Corée du Sud] ; Mi Jung Kim [Corée du Sud] ; Beom-Jun Kim [Corée du Sud] ; Sung Reul Kim [Corée du Sud] ; Sail Chun [Corée du Sud] ; Jin Sook Ryu [Corée du Sud] ; Ghi Su Kim [Corée du Sud] ; Myoung Chong Lee [Corée du Sud] ; Jung-Min Koh [Corée du Sud] ; Sun Ju Chung [Corée du Sud]	Homocysteine‐lowering therapy or antioxidant therapy for bone loss in Parkinson's disease
001E90 (2010)	Barry J. Snow [Nouvelle-Zélande] ; Fiona L. Rolfe [Nouvelle-Zélande] ; Michelle M. Lockhart [Nouvelle-Zélande] ; Christopher M. Frampton [Nouvelle-Zélande] ; John D. O'Sullivan [Australie] ; Victor Fung [Australie] ; Robin A. J. Smith [Nouvelle-Zélande] ; Michael P. Murphy [Royaume-Uni] ; Kenneth M. Taylor [Nouvelle-Zélande]	A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease
002483 (2009)	Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis]	A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohorts
002547 (2008)	Ilana Schlesinger [Israël] ; Naomi Schlesinger [États-Unis]	Uric acid in Parkinson's disease
004D85 (1999)	Patrick Chariot [France] ; Pierre Brugières [France] ; Marie-Christine Eliezer-Vanerot [France] ; Christian Gény [France] ; Michel Binaghi [France] ; Pierre Césaro [France]	Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathy
004F67 (1998)	Tetsuo Sakai [Japon] ; Jolyon Meara ; Peter Hobson	Letters to the Editor
005102 (1998)	I. Shoulson [États-Unis]	Where do we stand on neuroprotection? Where do we go from here?
005725 (1996)	Ranen [États-Unis] ; Carol E. Peyser [États-Unis] ; Joseph T. Coyle [États-Unis] ; Frederick W. Bylsma [États-Unis] ; Meeia Sherr [États-Unis] ; Leslie Day [États-Unis] ; Marshal F. Folstein [États-Unis] ; Jason Brandt [États-Unis] ; Christopher A. Ross [États-Unis] ; Susan E. Folstein [États-Unis]	A controlled trial of idebenone in Huntington's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antioxidants (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antioxidants (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antioxidants (therapeutic use)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024